INTEC PHARMA LTD. Share-based Payment Arrangement, Expense
INTEC PHARMA LTD. reported Share-based Payment Arrangement, Expense of $3.22 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2020-03-13
- INTEC PHARMA LTD. share-based payment arrangement, expense for the quarter ending 2019-06-30 was $1.02M, a 15.95% increase year-over-year.
- INTEC PHARMA LTD. share-based payment arrangement, expense for the quarter ending 2019-03-31 was $943.00K, a 30.43% increase year-over-year.
- INTEC PHARMA LTD. share-based payment arrangement, expense for the quarter ending 2018-06-30 was $878.00K.
- INTEC PHARMA LTD. share-based payment arrangement, expense for the quarter ending 2018-03-31 was $723.00K.
- INTEC PHARMA LTD. share-based payment arrangement, expense for fiscal 2019 was $3.22M, a 0.19% decline from fiscal 2018.
- INTEC PHARMA LTD. share-based payment arrangement, expense for fiscal 2018 was $3.23M, a 168.25% increase from fiscal 2017.
- INTEC PHARMA LTD. share-based payment arrangement, expense for fiscal 2017 was $1.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2019-12-31 | $3.22M 10-K · filed 2020-03-13 | ||
| 2019-06-30 | $1.02M 10-Q · filed 2019-08-09 | $1.96M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $943.00K 10-Q · filed 2019-05-07 | ||
| 2018-12-31 | $3.23M 10-K · filed 2020-03-13 | ||
| 2018-06-30 | $878.00K 10-Q · filed 2019-08-09 | $1.60M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $723.00K 10-Q · filed 2019-05-07 | ||
| 2017-12-31 | $1.20M 10-K · filed 2019-02-27 |